Is EHealth Stock a Good Investment?

EHealth Investment Advice

  EHTH
To provide specific investment advice or recommendations on eHealth stock, we recommend investors consider the following general factors when evaluating eHealth. This will help you to make an informed decision on whether to include EHealth in one of your diversified portfolios:
  • Examine EHealth's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research EHealth's leadership team and their track record. Good management can help EHealth navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Insurance Brokers space and any emerging trends that could impact EHealth's business and its evolving consumer preferences.
  • Compare EHealth's performance and market position to its competitors. Analyze how EHealth is positioned in terms of product offerings, innovation, and market share.
  • Check if EHealth pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about EHealth's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in eHealth stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if eHealth is a good investment.
 
Sell
 
Buy
Sell
Our trade advice tool can cross-verify current analyst consensus on eHealth and to analyze the company potential to grow for the next few years. To make sure EHealth is not overpriced, please confirm all eHealth fundamentals, including its ebitda, cash flow from operations, and the relationship between the price to book and total debt . Given that eHealth has a price to earning of 2.54 X, we urge you to verify eHealth market performance and probability of bankruptcy to ensure the company can sustain itself for the next few years given your prevailing risk tolerance and investing horizon.

Market Performance

SolidDetails

Volatility

Moderately volatileDetails

Hype Condition

Over hypedDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Very regressive towards the marketDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine EHealth Stock

Researching EHealth's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 61.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.58. Some equities with similar Price to Book (P/B) outperform the market in the long run. eHealth has Price/Earnings To Growth (PEG) ratio of 0.72. The entity recorded a loss per share of 2.62. The firm had not issued any dividends in recent years.
To determine if EHealth is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding EHealth's research are outlined below:
eHealth is way too risky over 90 days horizon
eHealth appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 452.87 M. Net Loss for the year was (28.21 M) with profit before overhead, payroll, taxes, and interest of 463.12 M.
eHealth currently holds about 164.75 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.01.
eHealth has a frail financial position based on the latest SEC disclosures
Roughly 61.0% of the company shares are held by institutions such as insurance companies
Latest headline from gurufocus.com: eHealth Inc Shares Up 3.18 percent on Jan 16
EHealth uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in eHealth. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EHealth's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact EHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises EHealth's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2013-10-24
2013-09-300.020.01-0.0150 
2013-04-25
2013-03-310.10.110.0110 
2014-10-30
2014-09-300.060.080.0233 
2013-07-25
2013-06-300.080.06-0.0225 
2013-02-14
2012-12-310.130.11-0.0215 
2011-04-26
2011-03-310.070.090.0228 
2010-07-27
2010-06-300.150.13-0.0213 
2009-02-12
2008-12-310.120.140.0216 

EHealth Target Price Consensus

EHealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. EHealth's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   5  Buy
Most EHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand EHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of eHealth, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

EHealth Target Price Projection

EHealth's current and average target prices are 10.05 and 8.62, respectively. The current price of EHealth is the price at which eHealth is currently trading. On the other hand, EHealth's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

EHealth Market Quote on 17th of January 2025

Low Price9.75Odds
High Price10.25Odds

10.05

Target Price

Analyst Consensus On EHealth Target Price

Low Estimate7.85Odds
High Estimate9.57Odds

8.625

Historical Lowest Forecast  7.85 Target Price  8.63 Highest Forecast  9.57
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on eHealth and the information provided on this page.

EHealth Analyst Ratings

EHealth's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about EHealth stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of EHealth's financials, market performance, and future outlook by experienced professionals. EHealth's historical ratings below, therefore, can serve as a valuable tool for investors.

Know EHealth's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as EHealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading eHealth backward and forwards among themselves. EHealth's institutional investor refers to the entity that pools money to purchase EHealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
318.3 K
Millennium Management Llc2024-09-30
221 K
Jacobs Levy Equity Management, Inc.2024-09-30
212.6 K
Atom Investors Lp2024-09-30
210.8 K
Assenagon Asset Management Sa2024-09-30
194.7 K
D. E. Shaw & Co Lp2024-09-30
184.6 K
Redwood Capital Management, Llc2024-09-30
175.4 K
Amvescap Plc.2024-09-30
154.8 K
Two Sigma Advisers, Llc2024-09-30
148.8 K
Palo Alto Investors, Llc2024-09-30
2.3 M
Nantahala Capital Management, Llc2024-09-30
1.9 M
Note, although EHealth's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

EHealth's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 293.08 M.

Market Cap

386.1 Million

EHealth's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.02)(0.02)
Return On Capital Employed(0.03)(0.03)
Return On Assets(0.02)(0.02)
Return On Equity(0.04)(0.03)
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.74) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.74.
Determining EHealth's profitability involves analyzing its financial statements and using various financial metrics to determine if EHealth is a good buy. For example, gross profit margin measures EHealth's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of EHealth's profitability and make more informed investment decisions.

Evaluate EHealth's management efficiency

eHealth has return on total asset (ROA) of (0.0125) % which means that it has lost $0.0125 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0421) %, meaning that it created substantial loss on money invested by shareholders. EHealth's management efficiency ratios could be used to measure how well EHealth manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.02. The current Return On Capital Employed is estimated to decrease to -0.03. As of now, EHealth's Other Current Assets are increasing as compared to previous years. The EHealth's current Total Current Assets is estimated to increase to about 461.7 M, while Other Assets are projected to decrease to under 147.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 29.04  30.50 
Tangible Book Value Per Share 28.29  29.70 
Enterprise Value Over EBITDA(29.10)(27.64)
Price Book Value Ratio 0.24  0.23 
Enterprise Value Multiple(29.10)(27.64)
Price Fair Value 0.24  0.23 
Enterprise Value266.5 M350.9 M
Understanding the operational decisions made by EHealth management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta
0.48

Basic technical analysis of EHealth Stock

As of the 17th of January 2025, EHealth shows the Risk Adjusted Performance of 0.1898, downside deviation of 3.31, and Semi Deviation of 2.34. eHealth technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

EHealth's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on EHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

EHealth's Outstanding Corporate Bonds

EHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. eHealth uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EHealth bonds can be classified according to their maturity, which is the date when eHealth has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand EHealth's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing EHealth's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider EHealth's intraday indicators

EHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

EHealth Corporate Filings

F4
14th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
17th of December 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
F3
26th of September 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
EHealth time-series forecasting models is one of many EHealth's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

EHealth Stock media impact

Far too much social signal, news, headlines, and media speculation about EHealth that are available to investors today. That information is available publicly through EHealth media outlets and privately through word of mouth or via EHealth internal channels. However, regardless of the origin, that massive amount of EHealth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of EHealth news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of EHealth relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to EHealth's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive EHealth alpha.

EHealth Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards EHealth can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

EHealth Corporate Management

Gavin GalimiGeneral VPProfile
Kate CFASenior StrategyProfile
Eli NewbrunMintzSenior ManagerProfile
John DolanChief OfficerProfile
Bill BillingsChief OfficerProfile
Bob ReesSenior OfficerProfile
Jay JenningsSenior FinanceProfile
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.108
Earnings Share
(2.62)
Revenue Per Share
16.016
Quarterly Revenue Growth
(0.1)
Return On Assets
(0.01)
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between EHealth's value and its price, as these two are different measures arrived at by various means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.